EPA v. Pfizer Pharmaceuticals LLC
Source Agrees
Case summary
A self-disclosure regarding violations at the facility was submitted to the U.S. EPA on June 25, 2010 under the Audit Policy. The disclosure indicated that the company had failed to file TRI Form R reports for tert-butyl alcohol for calendar years 2005, 2006, and 2007 as required by Section 313 of the Emergency Planning and Community Right-to-Know Act. The required Form R reports for 2006 and 2007 were submitted on July 20, 2010 and for 2005 on July 19, 2010.
Defendants (1)
- Pfizer Pharmaceuticals LLCNamed in settlement
Facilities (1)
PFIZER PHARMACEUTICALS LLC
PR-2 KM 58.2, BARCELONETA, PR, 00617
Registry ID: 110008472063
Statutes cited
- EPCRA 313 — Toxic Chemical Release Reporting (TRI)
Enforcement conclusions (1)
Pfizer Pharmaceuticals LLCentered 2012-08-22
Primary law: EPCRA
Timeline (3 milestones)
- 2012-08-22Final Order Issued
- 2012-08-22Enforcement Action Closed
- 2012-08-23Enforcement Action Data Entered
Case metadata
- EPA activity ID
- 3000050679
- Case number
- 02-2012-0831
- Lead agency
- EPA
- Branch
- WTS
- EPA region
- 02
- Voluntary self-disclosure
- Yes
- Primary statute
- Toxic Chemical Release Reporting (TRI)
Sourced verbatim from EPA ECHO Enforcement Case Report for case 02-2012-0831 . Bulk data: ICIS-FEC download summary.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.